Lisa A. Robinson

Harvard University - Department of Health Policy & Management

Deputy Director, Center for Health Decision Science, Senior Research Scientist

718 Huntington Avenue

Harvard T.H. Chan School of Public Health

Boston, MA 02115

United States

http://https://hsph.harvard.edu/profile/lisa-robinson/

Harvard Center for Risk Analysis (HCRA)

Senior Research Scientist

Harvard T.H. Chan School of Public Health

718 Huntington Avenue

Boston, MA 02115

United States

http://https://hsph.harvard.edu/research/risk-analysis/

SCHOLARLY PAPERS

11

DOWNLOADS

2,083

TOTAL CITATIONS

37

Scholarly Papers (11)

1.

Reference Case Guidelines for Benefit-Cost Analysis in Global Health and Development

Number of pages: 126 Posted: 07 Feb 2022
Harvard University - Department of Health Policy & Management, Harvard University, Organization for Economic Co-Operation and Development (OECD), Center for Global Development, University of York (UK) - Department of Economics and Related Studies, University of Maryland - Department of Economics, World Bank - Health, Nutrition and Population, Results for Development, University of California, Riverside (UCR) - Department of Economics, Inter-American Development Bank, University of California, San Francisco (UCSF) - Institute for Global Health Sciences, Seoul National University, University of Strathclyde, Harvard T.H. Chan School of Public Health, The Bill & Melinda Gates Foundation - Global Development Program, University of North Carolina (UNC) at Chapel Hill - Department of Environmental Sciences and Engineering, University of Cape Town (UCT), The Bill & Melinda Gates Foundation - Global Development Program and University of Copenhagen - Copenhagen University
Downloads 592 (95,559)

Abstract:

Loading...

benefit-cost analysis, cost-benefit analysis, low- and middle-income countries, value per statistical life (VSL), willingness to pay, distribution

2.

Benefit-Cost Analysis in Global Health

Forthcoming as Chapter 7 in: Global Health Priority-Setting: Beyond Cost-Effectiveness (O. Norheim et al., eds.), Oxford, UK and New York, NY: Oxford University Press.
Number of pages: 21 Posted: 17 Apr 2017
Lisa A. Robinson and James K. Hammitt
Harvard University - Department of Health Policy & Management and Harvard University
Downloads 297 (211,519)
Citation 4

Abstract:

Loading...

benefit-cost analysis, benefit valuation, morbidity risk reduction, mortality risk reduction, value per statistical life

3.

Efficient Warnings, Not "Wolf or Puppy" Warnings

HKS Working Paper No. RWP16-033
Number of pages: 32 Posted: 17 Sep 2016 Last Revised: 07 Dec 2016
Lisa A. Robinson, W. Kip Viscusi and Richard J. Zeckhauser
Harvard University - Department of Health Policy & Management, Vanderbilt University - Law School and Harvard University - Harvard Kennedy School (HKS)
Downloads 296 (212,302)
Citation 2

Abstract:

Loading...

4.

Economic Evaluation for Health Priority-Setting: Cost-Effectiveness Analysis and Benefit-Cost Analysis Primer

Disease Control Priorities Fourth Edition, Volume 3, Interventions Outside the Health Care System, Working Paper 3, February 2024
Number of pages: 22 Posted: 05 Mar 2024
Lisa A. Robinson and James K. Hammitt
Harvard University - Department of Health Policy & Management and Harvard University
Downloads 177 (348,971)

Abstract:

Loading...

benefit-cost analysis, cost-effectiveness analysis, public health

Valuing Mortality Risk Reductions: Progress and Challenges

Resources for the Future Discussion Paper No. 11-10
Number of pages: 34 Posted: 19 Mar 2011
Maureen Cropper, James K. Hammitt and Lisa A. Robinson
University of Maryland - Department of Economics, Harvard University and Harvard University - Department of Health Policy & Management
Downloads 121 (478,450)
Citation 6

Abstract:

Loading...

value of a statistical life, mortality risk reduction, hedonic wage studies, stated preference studies

Valuing Mortality Risk Reductions: Progress and Challenges

NBER Working Paper No. w16971
Number of pages: 36 Posted: 25 Apr 2011 Last Revised: 17 May 2023
Maureen Cropper, James K. Hammitt and Lisa A. Robinson
University of Maryland - Department of Economics, Harvard University and Harvard University - Department of Health Policy & Management
Downloads 54 (781,438)

Abstract:

Loading...

Valuing Mortality Risk Reductions: Progress and Challenges

Annual Review of Resource Economics, Vol. 3, Issue 1, pp. 313-336, 2011
Posted: 16 Sep 2011
Maureen Cropper, James K. Hammitt and Lisa A. Robinson
University of Maryland - Department of Economics, Harvard University and Harvard University - Department of Health Policy & Management

Abstract:

Loading...

6.

Do the Benefits of COVID-19 Policies Exceed the Costs? Exploring Uncertainties in the Age-VSL Relationship

Robinson, L.A., R. Sullivan, J. Shogren, Do the Benefits of COVID-19 Policies Exceed the Costs? Exploring Uncertainties in the Age-VSL Relationship, Risk Analysis, Early View, 2020.
Number of pages: 13 Posted: 15 Jun 2020 Last Revised: 20 Jul 2020
Lisa A. Robinson, Ryan Sullivan and Jason F. Shogren
Harvard University - Department of Health Policy & Management, Naval Postgraduate School and University of Wyoming
Downloads 151 (399,801)
Citation 13

Abstract:

Loading...

Value per Statistical Life, VSL, COVID-19, Pandemic, Willingness to Pay, Benefit-Cost Analysis

7.

Valuing Nonfatal Health Risk Reductions in Global Benefit‐Cost Analysis

Number of pages: 32 Posted: 07 Feb 2022
Lisa A. Robinson and James K. Hammitt
Harvard University - Department of Health Policy & Management and Harvard University
Downloads 127 (458,635)
Citation 9

Abstract:

Loading...

willingness to pay, nonfatal risk reductions, value per QALY, value per DALY, cost of illness

8.

Valuing Mortality Risk Reductions in Global Benefit‐Cost Analysis

Number of pages: 66 Posted: 28 Jan 2022
Lisa A. Robinson, James K. Hammitt and Lucy O'Keeffe
Harvard University - Department of Health Policy & Management, Harvard University and Harvard T.H. Chan School of Public Health
Downloads 106 (525,390)

Abstract:

Loading...

low- and middle-income countries, value of mortality risk reductions, value per statistical life (VSL), willingness to pay

9.

Assessing the Distribution of Impacts in Global Benefit‐Cost Analysis

Duke Law School Public Law & Legal Theory Series No. 2022-10
Number of pages: 33 Posted: 07 Feb 2022
Lisa A. Robinson, James K. Hammitt and Matthew D. Adler
Harvard University - Department of Health Policy & Management, Harvard University and Duke University School of Law
Downloads 92 (577,494)
Citation 3

Abstract:

Loading...

benefit-cost analysis, distributional analysis, equity, social welfare functions

The Benefits and Costs of U.S. Employer Covid-19 Vaccine Mandates

NBER Working Paper No. w30339
Number of pages: 68 Posted: 18 Aug 2022 Last Revised: 26 May 2023
Harvard University - T.H. Chan School of Public Health, Harvard University - Department of Health Policy & Management, Harvard T.H. Chan School of Public Health, Harvard University and Harvard University - T.H. Chan School of Public Health
Downloads 42 (872,408)

Abstract:

Loading...

The Benefits and Costs of U.S. Employer COVID-19 Vaccine Mandates

IZA Discussion Paper No. 15472
Number of pages: 69 Posted: 22 Aug 2022
Harvard University - T.H. Chan School of Public Health, Harvard University - Department of Health Policy & Management, Harvard T.H. Chan School of Public Health, Harvard T.H. Chan School of Public Health and Harvard University - T.H. Chan School of Public Health
Downloads 28 (1,007,262)

Abstract:

Loading...

benefit-cost analysis, COVID-19, vaccination, regulation, valueper statistical life (VSL), willingness to pay (WTP)

11.

Policy Monitorhow Us Government Agencies Value Mortality Risk Reductions

Review of Environmental Economics and Policy, Vol. 1, Issue 2, pp. 283-299, 2007
Posted: 27 Oct 2008
Lisa A. Robinson
Harvard University - Department of Health Policy & Management

Abstract:

Loading...